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Aim: Percutaneous coronary intervention (PCI) became the standard of care for patients
(pts) with acute coronary syndromes (ACS). Czech Republic is among European countries
with well developed networks of PCI and non-PCI hospitals. Ample data about PCI-treated
pts is available from many registries. Much less is known about treatments and outcomes
of ACS pts admitted to hospitals without cath-lab. ALERT-CZ registry was designed
speciﬁcally to analyze these pts presenting to local non-PCI hospitals. The aim was to
see, whether the ESC guidelines are implemented in these local, small hospitals.
Methods and results: A total of 6265 pts with ﬁrst hospital admission for ACS has been
enrolled in 32 Czech community hospitals without cath-lab during a 3-year period
(7/2008–6/2011). The mean age was 69.7712.3 years, 39.5% were females, 35.4% had known
diabetes mellitus, 76.0% hypertension, 28.3% previous myocardial infarction and 12.0%
previous stroke. Twenty-ﬁve percent pts had signs of acute heart failure (Killip II in 19.0%,
Killip III in 4.8% and Killip IV in 1.1%). The discharge diagnosis was ST-elevation myocardial
infarction (STEMI) in 26.1%, non-STEMI in 53.1% and unstable angina pectoris (UAP)
in 20.9%.
Emergent interhospital transport to coronary angiography (CAG) and PCI within
o12 h from symptom onset was indicated in 73.4% of STEMI pts, elective CAG was
indicated in 15.9% of STEMI, CAG was not indicated in 9.9% of STEMI and 0.9% STEMI pts
refused CAG. Among non-STE ACS pts CAG was performed within o24 h in 16.2%,
between 24–72 h in 18.2%, later in 38.1%, not indicated in 22.7%, refused by pts in 4.8%.
The median stay in the PCI center was 2.0 days and only 37% pts returned after CAG
(7PCI) to the referring community hospital, the rest was discharged from PCI center
directly to home.ch Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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c o r e t v a s a 5 5 ( 2 0 1 3 ) e 2 0 7 – e 2 1 1e208Among STEMI pts the median time intervals were: pain—ﬁrst medical contact (FMC)
120 min, FMC—community hospital door 30 min, door-in–door-out for emergency
transfer 23 min. Thrombolysis was used in 0.4% of STEMI—in rare situations when
immediate transfer was logistically not possible.
PCI was performed in 41.6% pts overall (65.9% STEMI, 35.8% non-STEMI and 26.4%
UAP). CABG was performed in 2.9% pts overall (2.1%, 3.1% and 3.6% per diagnosis).
Detailed pharmacotherapy data as well as indirect comparison with a separate PCI
centers registry is beyond the space frame of this abstract and will be presented.
The overall in-hospital mortality was 7.2%. Mortality per ﬁnal diagnosis was 9.5%
(STEMI), 8.7% (non-STEMI) and 0.5% (UAP). Mortality per age group was 16.2% (480
years), 8.0% (70–80 years) and 2.4% (o70 years).
Conclusion: Patients presenting to non-PCI hospitals undergo revascularization proce-
dures less frequently than those directly admitted to PCI centers. This may be related to
baseline differences. The outcomes are inﬂuenced by these facts.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o.
All rights reserved.
.1. Introduction
Percutaneous coronary intervention (PCI) became the stan-
dard of care for patients with acute coronary syndromes
(ACS). The European Society of Cardiology (ESC) guidelines [1]
recommend emergent (primary) PCI as the initial reperfusion
therapy for all patients with ST-segment elevation acute
myocardial infarction (STEMI), who present within 12 h from
symptom onset and in whom such therapy can be initiated
within 120 min from diagnostic 12-lead electrocardiogram
(ECG). ESC guidelines for non-ST elevation ACS [2] recom-
mend acute coronary angiography (with PCI whenever indi-
cated) withino2 h from hospital admission for high risk non-
STE ACS and within o24–72 h for those at intermediate risk.
Ample data about PCI-treated pts is available from many
registries [3–9]. Much less is known about treatments and
outcomes of ACS pts admitted to hospitals without cath-lab.
Thus, the ALERT-CZ (Acute coronary syndromes—Longitudinal
Evaluation of Real-life Treatment in non-PCI hospitals in the Czech
Republic) registry was designed speciﬁcally to analyze these
pts presenting to local non-PCI hospitals. The aim was to see,
whether the ESC guidelines are implemented in these local,
small hospitals.2. Methods
The Czech Republic is one of the European countries with
well developed networks of PCI and non-PCI hospitals. The
country population 10.5 million is served by 22 PCI centers
adequately distributed across all 13 counties. All 22 PCI
centers routinely offer non-stop (24/7) PCI services.
The ALERT-CZ registry enrolled 6265 patients with their
ﬁrst hospital admission for ACS in 32 Czech community
hospitals without catheterization facilities during a 3-year
period (July 1, 2008–June 30, 2011). The baseline characteristic
of the enrolled patients is described in Table 1.
The registry was organized and coordinated by the Cardi-
ocenter, Third Faculty of Medicine, Charles University Prague.
Data was collected via a dedicated electronic case report formprepared and managed by the EuroMISE center of Charles
University and Academy of Sciences of the Czech Republic.
The patients baseline characteristics, pharmacotherapy,
revascularization therapy and in-hospital outcomes were
registered.
2.1. Statistical methods
The paper presents some results of descriptive statistics
calculated from data of all ACS patients and in subgroups of
STEMI, non-STEMI a UAP patients. Most of basic statistical
characteristics are expressed in percentages—no inductive
statistical methods are presented in this paper.3. Results
3.1. In-Hospital outcomes
The overall in-hospital mortality was 7.2%. Mortality per ﬁnal
diagnosis was 9.5% (STEMI), 8.7% (non-STEMI) and 0.5% (UAP).
Mortality per age group was 16.2% (480 years), 8.0% (70–80
years) and 2.4% (o70 years). Mortality per sex was 5.8%
(males) and 9.3% (females). Mortality in revascularized (PCI/
CABG) patients was 2.1% (n¼2725), and in non-revascularized
11.3% (n¼3468). Mortality data in additional subgroups are in
Table 2.
A new stroke during this hospital stay occurred in 0.6% of
patients. Cardiogenic shock developed during the hospital
stay in 4.9% of patients (8.7% STEMI, 4.8% non-STEMI and
0.4% UAP)—on top of those 1.1% patients in whom the shock
was present upon initial presentation. The clinical diagnosis of
recurrent myocardial infarction during the hospital stay was
done in 2.3% of patients. Among the patients transferred to
PCI centers, the mean stay in the PCI center was 2.973.1 days
and only 37% pts returned after CAG (7PCI) to the referring
community hospital, the rest was discharged from PCI center
directly to home. PCI was performed in 41.6% pts overall
(65.9% STEMI, 35.8% non-STEMI and 26.4% UAP). CABG was
performed in 2.9% pts overall (2.1%, 3.1% and 3.6% per
diagnosis).
Table 2 – Mortality in subgroups.
Mortality [%] All Revascularized (PCI/CABG) Non-revascularized
STEMI 9.5 4.1 20.9
non-STEMI 8.7 1.0 13.6
UAP 0.5 0.0 0.7
Age o70 years 2.4 0.4 4.7
Age 70–80 years 8.0 3.2 11.3
Age 480 years 16.2 6.9 19.5
Males 5.8 1.7 10.0
Females 9.3 2.8 13.0
Table 1 – The key baseline characteristic of ALERT-CZ patients.
All ACS patients STEMI Non-STEMI UAP
N¼ 6265 1630 (26.1%) 3319 (53.1%) 1306 (20.9%)
Mean age 69.7712.3 66.3 71.3 69.9
Females (%) 39.5 32.4 41.9 41.9
Diabetes mellitus (%) 35.4 26.0 39.5 36.4
Hypertension (%) 76.0 63.7 78.2 85.8
Previous myocardial infarction (%) 28.3 15.0 29.7 41.3
Previous stroke (%) 12.0 8.6 13.7 11.7
Killip II on admission (%) 19.0 16.1 21.6 16.2
Killip III on admission (%) 4.8 4.4 6.3 1.5
Killip IV on admission (%) 1.1 2.2 1.0 0.0
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The emergent interhospital transport to coronary angiogra-
phy (CAG) and PCI within o12 h from symptom onset was
indicated in 73.4% of STEMI pts, elective CAG was indicated in
15.9% of STEMI, CAG was not indicated in 9.9% of STEMI and
0.9% STEMI pts refused CAG. The mean time intervals were:
pain—ﬁrst medical contact (FMC) 45071410 min (median
120 min), FMC—community hospital door 44760 min (med-
ian 30 min), door-in–door-out for emergency transfer
577167 min (median 23 min). Thrombolysis was used in
0.4% of STEMI—in rare situations when immediate transfer
was logistically not possible.
3.3. Non-STE ACS subgroup
Among non-STE ACS pts CAG was performed withino24 h in
16.2%, between 24–72 h in 18.2%, later in 38.1%, not indicated
in 22.7%, refused by pts in 4.8%.4. Discussion
4.1. Study limitations
The main study limitation is that in most hospitals the
patient enrollment was not done on a consecutive way. Some
hospitals enrolled almost all their ACS patients, while others
only a small proportion. Furthermore, this registry cannot
provide complete picture about ACS treatment in the country
because patients with STEMI or with severe non-STEMI (e.g.
complicated by acute heart failure and ST depressions) whocall the emergency medical service number 155 are usually
bypassing the nearest non-PCI hospital and are directly
admitted to a PCI center. Thus, the population presented in
this manuscript is largely composed from those ACS patients
who presented themselves (or by a family member) to the
nearest hospital.
4.2. Reperfusion treatment for STEMI
In general, the proportion of patients with STEMI referred for
primary reperfusion was lower than expected. The explana-
tion has three components: (1) the most clinically apparent
STEMI patients bypassed these non-PCI hospitals as men-
tioned above, (2) many of the STEMI patients treated con-
servatively presented after 412 h from symptom onset,
(3) some patients (usually the very elderly) presented with
atypical symptoms and/or had multiple co-morbidities and
were thus considered not suitable for transfer to a PCI center.5. Conclusion
Patients presenting to non-PCI hospitals undergo revascular-
ization procedures less frequently than those directly
admitted to PCI centers. This may be related to baseline
differences. The outcomes are inﬂuenced by these facts.Acknowledgments
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The list of participating hospitals and investigators with
number of enrolled patients in these hospitals:Investigator: Hospital: Pts
enrolled:MUDr. Pavel
JežilNemocnice Chomutov 53MUDr. Ivana
KellnerováSvitavská nemocnice 118MUDr. Jitka
KobrlováMasarykova městská
nemocnice v Jilemnici119MUDr. Pavel
TřeštíkKroměřížská nemocnice 647MUDr.
Michaela
MelounováNemocnice Sušice 87MUDr. Josef
ŠtumarNemocnice Třebíč 159MUDr. Josef
PolaNemocnice Tanvald 93MUDr. Hana
GrünfeldováMěstská nemocnice
Čáslav164MUDr. Olga
ŠantorováRokycanská nemocnice 153MUDr. Zdeněk
Monhart, Ph.D.Nemocnice Znojmo 567MUDr. Martina
KalováMěstská nemocnice v
Litoměřicích163MUDr. Kamil
Zeman, Ing.Nemocnice ve Frýdku-
Místku402MUDr. Jakub
TocháčekStodská nemocnice 84MUDr.
Veronika
SedlákováOblastní nemocnice
Kladno273MUDr. Gabriel
MarcinekNemocnice Slaný 173Doc. MUDr.
Josef Jandík,
CSc.Oblastní nemocnice
Náchod76Doc. MUDr.
Karel Sochor,
CSc.Jessenia, a. s., Nemocnice
Beroun36MUDr. Pavel
ŠímaOblastní nemocnice
Mladá Boleslav915MUDr. Michal
HondlKrajská zdravotní, a. s.,
Nemocnice Děčín74MUDr. Jan
VohralíkKarlovarská krajská
nem., a. s., Nemocnice
Cheb311MUDr. Oldřich
HoncůPanochova nemocnice
Turnov146MUDr. Kamil
TachirNemocnice Nové Město
na Moravě277MUDr. Libor
HoráčekNemocnice sv. Zdislavy,
a. s., Velké Meziříčí16MUDr. David
GerberDomažlická nemocnice 201MUDr. Pavel
SáblNemocnice s poliklinikou
v Semilech162MUDr. Hana
FroňkováMěstská nem. PRIVAMED
Healthia Rakovník76MUDr.
Vratislav
DědekOrlickoústecká
nemocnice127MUDr. Tomáš
MičkalNemocnice Hranice 11MUDr. Ivan
AndrOblastní nemocnice
Trutnov71MUDr.
Vladimír KapalUherskohradišt'ská
nemocnice457MUDr. Jan
ŠvejdaNem. Milosrdných sester
K. Borom. v Praze17MUDr. Jan
SemrádNemocnice sv. Alžběty,
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